The Patent Finder

Terms ending in 2032

CSL Behring GmbH

Every in-force patent on CSL Behring GmbH's record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,352,016Factor XII Inhibitors for the Administration with Medical Procedures Comprising Contact with Artificial Surfaces
In force
 · High confidence
CSL Behring GmbHIn forceHigh confidence
US 9,624,307Factor XII Inhibitors for the Treatment of Silent Brain Ischemia and Ischemia of Other Organs
In force
 · High confidence
CSL Behring GmbHIn forceHigh confidence
US 9,987,328Factor XII Inhibitors for the Administration with Medical Procedures Comprising Contact with Artificial Surfaces
In force
 · Medium confidence
CSL Behring GmbHIn forceMedium confidence
US 9,856,325Nucleic Acids Encoding Inhibitory Anti-Factor XII/Xiia Monoclonal Antibodies
In force
 · High confidence
CSL Behring GmbHIn forceHigh confidence
US 9,856,326Methods of Administering Inhibitory Anti-Factor XII/Xiia Monoclonal Antibodies
In force
 · High confidence
CSL Behring GmbHIn forceHigh confidence
US 10,513,560Methods of Administering Inhibitory Anti-Factor XII/Xiia Monoclonal Antibodies
In force
 · High confidence
CSL Ltd.In forceHigh confidence
US 12,558,422Immunoglobulin Preparation and Storage System for an Immunoglobulin Preparation
In force
 · Low confidence
CSL Behring AGIn forceLow confidence
US 9,452,203Use of C1-INHIBITOR for the Treatment of Secondary Edema of the Central Nervous System
In force
 · High confidence
CSL Behring GmbHIn forceHigh confidence
8 of 8 patents shown. Soonest term end first, then patent number.
7 of these are in force and held by CSL Behring GmbH.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited